• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Emergency

Docosahexaenoic acid supplementation does not reduce risk of necrotizing enterocolitis among preterm infants

byAlex Xiang, MDandSimon Pan, MD
November 3, 2026
in Emergency, Gastroenterology, Infectious Disease, Pediatrics, Pharma
Reading Time: 2 mins read
Newborn intensive care collage: a sleeping newborn in a knit cap, swaddled in a white blanket inside an incubator
Share on FacebookShare on TwitterShare on LinkedIn

1. In preterm infants admitted to the neonatal intensive care unit (NICU), docosahexaenoic acid (DHA) supplementation did not significantly reduce the risk of necrotizing enterocolitis (NEC) compared to control.

Evidence Rating Level: 1 (Excellent)

NEC primarily affects premature infants and is associated with dysregulated immune responses. Long-chain polyunsaturated fatty acids (LCPUFAs) have been shown to be important for fetal and neonatal development of the gut and immune system. Previous studies have found preterm infants to be at risk for LCPUFA deficiencies. Despite this, it is unclear which LCPUFAs should be supplemented to prevent NEC, and in what ratio. This randomized clinical trial included infants admitted to the NICU born at a gestational age of less than 34 weeks. 62 infants were randomised to receive standard care (control group; n = 33; mean [SD] gestational age, 32.45 [1.47] weeks; 57.6% female) or 60 mg DHA/kg once daily for three consecutive days (DHA group; n = 29; mean [SD] gestational age, 33.18 [0.99] weeks; 44.8% female). There was no significant difference in NEC rates between the control and DHA groups (15/33, 45.5% vs. 7/29, 24.1%; RR 0.53; 95% CI 0.25 to 1.12; p = 0.112). No infants required NEC-related surgery. There were no significant differences in mortality (5/33 vs. 1/29; p = 0.201). Patients receiving DHA had a significantly higher risk of neutropenia compared to the control group (6/29, 20.7% vs. 0/33, 0.0%; p = 0.008). Overall, DHA supplementation did not significantly reduce NEC risk compared to control in premature infants admitted to the NICU, but it did significantly increase the risk of neutropenia.

Click here to read this study in BMC Pediatrics

Citation: Sabzevari F, Parvaz A, Rezaei M, Bijari BB, Jamali Z, Nikvarz M, et al. Docosahexaenoic acid in preventing necrotizing enterocolitis in preterm infants: a randomized clinical trial. BMC Pediatr. 2026 Oct 29. doi: 10.1186/s12887-026-07968-z. Epub ahead of print.

© 2026 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine

RELATED REPORTS

First-trimester doxycycline exposure may be linked to higher risk of pregnancy loss

2 Minute Medicine Rewind November 9, 2026

Tags: DHAinfantsNICUpretermrisk
Previous Post

AI-drafted responses to patient messages linked to faster reply times but no drop in after-hours work for clinicians

Next Post

Angiography-derived vessel fractional flow reserve (vFFR) was noninferior to pressure wire–based fractional flow reserve (FFR) for guiding revascularization in intermediate coronary stenoses

RelatedReports

Miscarriage collage of a sprig of small white flowers, two mugs side by side and a folded knitted blanket on torn paper
All Specialties

First-trimester doxycycline exposure may be linked to higher risk of pregnancy loss

November 10, 2026
A profile of a human head with a visible brain, surrounded by descending bar graphs and doors leading into a fading background, suggesting themes of dementia and cognitive decline.
Weekly Rewinds

2 Minute Medicine Rewind November 9, 2026

November 11, 2026
A variety of pharmaceutical items including a vial, capsule, molecule model, pill blister pack, petri dish with a pipette, and a graph, symbolizing drug development.
Pharma Roundup

2MM: Pharma Roundup – First DNA therapy approved which could reduce airway surgeries, novel siRNA targets dual lipid pathways, GLP-1s outperform metformin in prediabetes, and Zolgensma tumor risks under FDA review

November 9, 2026
Heart catheter procedures collage: a smiling older man with a white beard and an engraved heart with a blue guidewire
Cardiology

In At-Risk Patients With Moderate Aortic Stenosis, TAVR Reduced 2-Year Death or Heart-Failure Events

November 8, 2026
Next Post
Cardiac catheterization collage: a heart with coronary arteries, a thin coiled catheter, a blank X-ray card and a woman

Angiography-derived vessel fractional flow reserve (vFFR) was noninferior to pressure wire–based fractional flow reserve (FFR) for guiding revascularization in intermediate coronary stenoses

CLL collage: a cluster of round lymphocytes, a drawing of the spleen, a blank calendar page and a closed pocket watch

Pirtobrutinib improves progression-free survival versus bendamustine plus rituximab in previously untreated CLL/SLL

Emergency care collage: an empty hospital stretcher with a pillow and sheet before blue double doors with round windows

Non-inpatient care settings may offer alternatives to inpatient beds for select patients

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Use of colchicine is not associated with reduced cardiovascular events among Chinese adults starting urate-lowering therapy
  • ARO-DIMER-PA can Significantly Lower LDL-C and Triglycerides in Patients with Mixed Hyperlipidemia
  • CCTA-guided PCI noninferior to IVUS-guided PCI for target-vessel failure
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.